NYSE: XXITwenty One Capital Inc Stock
$11.96+0.54 (+4.73%)
Updated Dec 10, 2025
XXI Price
$11.96
Fair Value Price
-$0.02
Market Cap
$153.09M
52 Week Low
$10.26
52 Week High
$59.75
P/E
29.9x
P/B
-89.95x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$4.35M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.19
Operating Cash Flow
-$97
Beta
0.77
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XXI Overview
Cantor Equity Partners, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the financial services, healthcare, real estate services, technology, and software industries. The company was formerly known as CF Acquisition Corp. A. and changed its name to Cantor Equity Partners, Inc. in June 2024. Cantor Equity Partners, Inc. was incorporated in 2020 and is based in New York, New York.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XXI's potential to beat the market
- XXI doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
XXI
RankedUnranked of 30
RankedUnranked of 30
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.00 | C | |
| $10.24 | C | |
| $10.19 | C |
Be the first to know about important XXI news, forecast changes, insider trades & much more!
XXI News
Overview
Due Diligence Score
–
Industry Average (6)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XXI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XXI ($11.96) is overvalued by 49,805.19% relative to our estimate of its Fair Value price of -$0.02 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
XXI ($11.96) is not significantly undervalued (49,805.19%) relative to our estimate of its Fair Value price of -$0.02 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
XXI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
There are 30 more XXI due diligence checks available for Premium users.
Valuation
XXI fair value
Fair Value of XXI stock based on Discounted Cash Flow (DCF)
Price
$11.96
Fair Value
-$0.02
Undervalued by
49,805.19%
XXI ($11.96) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XXI ($11.96) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XXI price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.9x
Industry
12.38x
Market
46.23x
XXI is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XXI is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
XXI price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-89.95x
Industry
-52.57x
XXI's financial health
Profit margin
Revenue
$0.0
Net Income
$2.1M
Profit Margin
0%
XXI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$107.1M
Liabilities
$2.0M
Debt to equity
-1.19
XXI's short-term liabilities ($2.02M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XXI's short-term assets ($254.41k) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XXI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XXI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$0.0
Investing
$0.0
Financing
$0.0
XXI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
XXI vs Shell Company Stocks
Twenty One Capital Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.